Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04CXX
|
|||
Former ID |
DNCL002120
|
|||
Drug Name |
GNKG-168
|
|||
Indication | Chronic lymphocytic leukaemia [ICD-11: 2A82.0; ICD-10: C83.0, C91.1] | Phase 1 | [1] | |
Company |
SBI Biotech
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01743807) Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia. U.S. National Institutes of Health. | |||
REF 2 | National Cancer Institute Drug Dictionary (drug id 662816). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.